H2020Individual fellowship2015–2017

NanoCytox · Development of Novel Analytical Methods to assess Nanoparticle cytotoxicity

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2015-11-01 → 2017-10-31
EU contribution
€159,461
Participants
1
Scheme
MSCA-IF-EF-ST

Lines connect the coordinator with its partners.

Results in brief

Development of Novel Analytical Methods to assess Nanoparticle cytotoxicity

In the last decades, biomedical and numerous commercial applications using nanoparticles (NPs) with a size range of 1 to 100 nm have been established due to their unique chemical reactivity and physical properties. However, there are serious concern regarding exposure, distribution and accumulation of NPs in organisms and environment. In particular, the impact of NPs on cells is a key question in biomedical applications as well as in nanotoxicology and numerous analytical methods have been applied to understand the extent and mode of cell-NP interactions. However, such methodologies are still in its infancy to resolve cell-associated NPs uptake and the analysis of NPs at single cell level remains a challenge. So far, the mechanisms of cell-NPs interactions are not well understood yet and the development and validation of new reliable methods that enable the analysis and identification of NPs at single cell level providing information of the number of NPs internalized by cells or externally bound to the cell surface are urgently required. The NanoCytox project has the main aim to develop analytical methodologies based on inductively coupled plasma mass spectrometry, ICP-MS, to evaluate the quantitative uptake and biological interaction of NPs with individual cells. The following methodologies have been evaluated here: A. Micro-droplet generator (µDG) for sample introduction of single cells into a quadrupole and/or into a sector field ICP-MS working in single particle mode, (sp)-ICP MS; B. Mass Cytometry, CyTOF (ICP-TOF MS). This method was originally not described in the NanoCytox project, but during our investigation we found out that it is the most promising one. It should be mentioned that these investigations were performed at the “Deutsche Rheuma Forschungs-Institute” at the Charité who is the owner of such an instrument. C. Pneumatic nebulization coupled to a quadrupole and/or sector field ICP MS working in a time resolved single particle mode, in the so-called single cell mode, SC-ICP MS. This method was also originally not described in the NanoCytox project, but during our investigation we found out it also promising. D. Laser ablation (LA) coupled to ICP-MS for spatially resolved bioimaging of the distribution of NPs in single cells upon different NPs incubation experiments.

Data: CORDIS, © European Union

Project objective

Nanoparticles , NPs, are being used to produce novel materials with unique physico-chemical properties with many applications in fields such as medicine, energy and electronics, consumer goods, among others. Some studies have revealed that the same specific properties that make NPs so unique could also be responsible for potential harmful effects on the environment and human health. Currently, the assessment of their impact is hampered by limited analytical capabilities to detect them in complex natural matrices. New sensitive and selective analytical methods must be developed and validated in order to elucidate their toxicological effects prior to increasing and promoting the NPs production. Herein, new analytical methodologies based on inductively coupled plasma mass spectrometry (ICP-MS) are proposed to evaluate the toxicity of metallic NPs in cells, one of the most powerful and attractive model systems for toxicological assays. The proposed methodology consists on the use of laser ablation (LA) coupled to ICP-MS for spatially resolved bioimaging of the distribution of NPs in single cells upon different NPs incubation experiments; furthermore, a micro-droplet generator (µDG) for sample introduction of single cells into a sector field ICP-MS will be employed to improve the NPs detection sensitivity. The expected results will give essential insights into nanoparticle/cell interactions and will have implications for the development of analytical methods based on applications of nano-particles for medical diagnostics and therapeutics.

Original text from CORDIS.

Participants

  • BUNDESANSTALT FUER MATERIALFORSCHUNG UND -PRUEFUNG · BerlinCoordinatorGermany

Links

Data: CORDIS, © European Union